Sign Up to like & get
recommendations!
0
Published in 2019 at "Cytokine"
DOI: 10.1016/j.cyto.2019.154877
Abstract: OBJECTIVE Langerhans cell histiocytosis (LCH) is a granulomatous inflammatory myeloid neoplasia associated with a cytokine storm in both serum and lesions. Increased levels of plasma interleukin-17A (IL-17A) in LCH patients have been reported, but this…
read more here.
Keywords:
langerhans cell;
levels plasma;
17a lch;
cell histiocytosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16923
Abstract: In the inflammatory myeloid neoplasia called Langerhans cell histiocytosis (LCH), leukocytes accumulate in tissues causing granulomatous lesions. The disease ranges from mild (singlesystem, SS) to severe (multisystem, MS) manifestations with potential involvement of risk organs…
read more here.
Keywords:
lymphopenia;
diagnosis;
treatment;
prevalence ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2024.1452003
Abstract: Purpose To retrospectively evaluate the clinical features and prognostic factors of pediatric LCH patients treated in a single center of China. Methods Pediatric LCH cases were treated following the SD-LCH protocol at the Affiliated Provincial…
read more here.
Keywords:
year;
clinical features;
features prognostic;
lch patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.780191
Abstract: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasm characterised by the accumulation into granulomas of apoptosis-resistant pathological dendritic cells (LCH-DCs). LCH outcome ranges from self-resolving to fatal. Having previously shown that, (i) monocyte-derived DCs…
read more here.
Keywords:
lch patients;
dcs lch;
neutralizing anti;
expression ... See more keywords